[1]
|
Han BF, Zheng RS, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 2024;4(1):47 − 53. |
[2]
|
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol 2021;116(3):458 − 79. |
[3]
|
Wang YF, Zhao L, Gao LW, Pan A, Xue H. Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol 2021;9(7):446 − 61. |
[4]
|
Zheng JC, Yao LA, Lei KT, Huang WY, Luo YJZ, Tran PHX, et al. Economic burden attributable to high BMI-caused cancers: a global level analysis between 2002 and 2021. BMC Med 2025;23(1):297. |
[5]
|
Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002;15(1):83-96. https://pubmed.ncbi.nlm.nih.gov/12046553/. |
[6]
|
Huang WD, Yang JJ, Liu Y, Liu CJ, Zhang X, Fu WQ, et al. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China. BMJ Open 2018;8(12):e022711. |
[7]
|
Chen HD, Li N, Ren JS, Feng XS, Lyu Z, Wei LP, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut 2019;68(8):1450 − 7. |
[8]
|
Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol 2018;6(12):944 − 53. |
[9]
|
National Health Commission Disease Control and Prevention Bureau. Report on the nutrition and chronic diseases status of Chinese residents. Beijing: People’s Medical Publishing House. 2021. https://www.zhangqiaokeyan.com/book-cn/081501101810.html (In Chinese). |
[10]
|
Zhao SQ, Xu XP, You H, Ge JJ, Wu QF. Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study. BMC Public Health 2023;23(1):1927. |
[11]
|
Yeoh A, Mannalithara A, Ladabaum U. Cost-effectiveness of earlier or more intensive colorectal cancer screening in overweight and obese patients. Clin Gastroenterol Hepatol 2023;21(2):507 − 19. |
[12]
|
Seibert RG, Hanchate AD, Berz JP, Schroy III PC. National disparities in colorectal cancer screening among obese adults. Am J Prev Med 2017;53(2):e41 − 9. |
[13]
|
Anderson JC, Fortinsky RH, Kleppinger A, Merz-Beyus AB, Huntington III CG, Lagarde S. Predictors of compliance with free endoscopic colorectal cancer screening in uninsured adults. J Gen Intern Med 2011;26(8):875 − 80. |